Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle

Chidambaram, Saravana Babu; Essa, Musthafa Mohamed; Rathipriya, A.G.; Bishir, Muhammed; Ray, Bipul; Mahalakshmi, Arehally M.; Tousif, A.H.; Sakharkar, Meena K.; Kashyap, Rajpal Singh; Friedland, Robert; Monaghan, Tanya M.

Abstract

The human microbiota comprises trillions of symbiotic microorganisms and is involved in regulating gastrointestinal (GI), immune, nervous system and metabolic homeostasis. Recent observations suggest a bidirectional communication between the gut microbiota and the brain via immune, circulatory and neural pathways, termed the Gut-Brain Axis (GBA). Alterations in gut microbiota composition, such as seen with an increased number of pathobionts and a decreased number of symbionts, termed gut dysbiosis or microbial intestinal dysbiosis, plays a prominent role in the pathogenesis of central nervous system (CNS)-related disorders. Clinical reports confirm that GI symptoms often precede neurological symptoms several years before the development of neurodegenerative diseases (NDDs). Pathologically, gut dysbiosis disrupts the integrity of the intestinal barrier leading to ingress of pathobionts and toxic metabolites into the systemic circulation causing GBA dysregulation. Subsequently, chronic neuroinflammation via dysregulated immune activation triggers the accumulation of neurotoxic misfolded proteins in and around CNS cells resulting in neuronal death. Emerging evidence links gut dysbiosis to the aggravation and/or spread of proteinopathies from the peripheral nervous system to the CNS and defective autophagy-mediated proteinopathies. This review summarizes the current understanding of the role of gut microbiota in NDDs, and highlights a vicious cycle of gut dysbiosis, immune-mediated chronic neuroinflammation, impaired autophagy and proteinopathies, which contributes to the development of neurodegeneration in Alzheimer's disease, Parkinson's disease, Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis and frontotemporal lobar degeneration. We also discuss novel therapeutic strategies targeting the modulation of gut dysbiosis through prebiotics, probiotics, synbiotics or dietary interventions, and faecal microbial transplantation (FMT) in the management of NDDs.

Citation

Chidambaram, S. B., Essa, M. M., Rathipriya, A., Bishir, M., Ray, B., Mahalakshmi, A. M., …Monaghan, T. M. (2022). Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharmacology and Therapeutics, 231, Article 107988. https://doi.org/10.1016/j.pharmthera.2021.107988

• Journal Article Type: Article
• Acceptance Date: Aug 25, 2021
• Online Publication Date: Sep 16, 2021
• Publication Date: 2022-03
• Deposit Date: Sep 23, 2021
• Publicly Available Date: Sep 17, 2022
• Journal: Pharmacology and Therapeutics
• Print ISSN: 0163-7258
• Electronic ISSN: 1879-016X
• Publisher: Elsevier BV
• Peer Reviewed: Peer Reviewed
• Volume: 231
• Article Number: 107988
• DOI: https://doi.org/10.1016/j.pharmthera.2021.107988
• Keywords: Pharmacology (medical); Pharmacology
• Public URL: https://nottingham-repository.worktribe.com/output/6296680
• Publisher URL: https://www.sciencedirect.com/science/article/abs/pii/S016372582100190X?via%3Dihub